We are aware of our social and economic impact and the long-term impact of the social environment on our operations.

By continuously investing in research and development, we provide patients worldwide with access to affordable, high-quality, safe and effective innovative generic medicines, which is a cornerstone of our social responsibility.

We treat all stakeholders responsibly, fostering good relations and encouraging adherence to our Diversity, Equity and Inclusion Policy. We maintain a healthy and attractive work environment with fair compensation and respect for human rights.

We are aware that we are part of the broader social environment; in exchange for a so-called “social licence to operate” we make sure we deliver a positive impact the development of the social community we operate in.

In the double materiality assessment process, we identified three key sustainability topics: accessible healthcare, product quality and patient safety, as well as talent attraction and retention.